| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.19 | 0.001 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.098 | 0.002 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.003 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.14 | 0.003 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.13 | 0.004 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.005 |